MRSN NASDAQ
Mersana Therapeutics, Inc.
1W: -0.2%
1M: +5.5%
3M: +264.4%
1Y: -22.9%
3Y: -80.0%
5Y: -95.8%
$29.08
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$33M
Revenue
-4.8% YoY
$-70M
Net Income
+6.1% YoY
$-74M
Free Cash Flow
+22.2% YoY
100.0%
Gross Margin
-67.9%
Op. Margin
-68.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE239.6%
ROA-60.4%
ROIC46.8%
Valuation
P/E-2.6
P/B-2.4
EV/EBITDA0.2
Leverage
Debt/Equity-0.04
Current Ratio1.39
Interest Cov.-24.5x
Quality Scores
Piotroski F2/9
Altman Z-23.76
Beneish M-3.37